Retour
IO Biotech Inc (IOBT) Gagner
Graphique du cours de l'action IOBT
IOBT Gagner
IO Biotech Inc
$0.2
-0.57%
$0
À partir d'aujourd'hui :Mar 24, 11:50:04 GMT-4
Statistiques clés
Clôture préc.
$0.209
Prix d'ouverture
$0.1975
Plage de la journée
$0.1909 - $0.214
Plage de 52 semaines
$0.14 - $2.79
Volume
478.5K
Volume moyen
10.4M
Rendement en dividend
--
BPA (TTM)
-1.34
Capitalisation boursière
$14.9M
Qu’est-ce que IOBT ?
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.